Cancer-related fatigue and associated disability in post-treatment cancer survivors

被引:266
作者
Jones, Jennifer M. [1 ]
Olson, Karin [2 ]
Catton, Pamela [1 ]
Catton, Charles N. [3 ]
Fleshner, Neil E. [4 ]
Krzyzanowska, Monika K. [5 ]
McCready, David R. [4 ]
Wong, Rebecca K. S. [3 ]
Jiang, Haiyan [6 ]
Howell, Doris [1 ]
机构
[1] Princess Margaret Canc Ctr, Univ Hlth Network, Canc Survivorship Program, Toronto, ON M5G 2C4, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Cancer-related fatigue; Post-treatment survivorship; Disability; PROPOSED DIAGNOSTIC-CRITERIA; BREAST-CANCER; FUNCTIONAL ASSESSMENT; ADJUVANT CHEMOTHERAPY; COMORBIDITY INDEX; PHYSICAL FUNCTION; DEPRESSION; DISEASE; PREVALENCE; THERAPY;
D O I
10.1007/s11764-015-0450-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer-related fatigue (CRF) is the most prevalent and distressing symptom among cancer patients and survivors. However, research on its prevalence and related disability in the post-treatment survivorship period remains limited. We sought to describe the occurrence of CRF within three time points in the post-treatment survivorship trajectory. A self-administered mail-based questionnaire which included the Functional Assessment of Cancer Therapy-Fatigue (FACT-F) and the World Health Organisation Disability Assessment Schedule 2.0 was sent to three cohorts of disease-free breast, prostate or colorectal cancer survivors (6-18 months; 2-3 years; and 5-6 years post-treatment). Clinical information was extracted from chart review. Frequencies of significant fatigue by diagnostic group and time cohorts were studied and compared. Multivariate logistic regressions were conducted to examine the associations between CRF and demographic, clinical, and psychosocial variables. One thousand two hundred ninety-four questionnaire packages were returned (63 % response rate). A total of 29 % (95 % CI [27 % to 32 %]) of the sample reported significant fatigue (FACT-F a parts per thousand currency sign34), and this was associated with much higher levels of disability (p < 0.0001). Breast (40 % [35 % to 44 %]) and colorectal (33 % [27 % to 38 %]) cancer survivors had significantly higher rates of fatigue compared with the prostate group (17 % [14 % to 21 %]) (p < 0.0001). Fatigue levels did not differ between the three time cohorts. The main factors associated with CRF included physical symptom burden, depression, and co-morbidity (AUC, 0.919 [0.903 to 0.936]). Clinically relevant levels of CRF are present in approximately 1/3 of cancer survivors up to 6 years post-treatment, and this is associated with high levels of disability. Clinicians need to be aware of the chronicity of CRF and assess for it routinely in medical practice. While there is no gold standard treatment, non-pharmacological interventions with established efficacy can reduce its severity and possibly minimize its disabling impact on patient functioning. Attention must be paid to the co-occurrence and need for possible treatment of depression and other co-occurring physical symptoms as contributing factors.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 105 条
[91]   Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy [J].
Smets, EMA ;
Garssen, B ;
Cull, A ;
deHaes, JCJM .
BRITISH JOURNAL OF CANCER, 1996, 73 (02) :241-245
[92]  
Spielberger C. D., 1970, Manual for the state-trait anxiety inventory
[93]   Fatigue in patients with prostate cancer receiving hormone therapy [J].
Stone, P ;
Hardy, J ;
Huddart, R ;
A'Hern, R ;
Richards, M .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) :1134-1141
[94]   Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey [J].
Stone, P ;
Richardson, A ;
Ream, E ;
Smith, AG ;
Kerr, DJ ;
Kearney, N .
ANNALS OF ONCOLOGY, 2000, 11 (08) :971-975
[95]   Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy [J].
Stone, P ;
Richards, M ;
A'Hern, R ;
Hardy, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (06) :1007-1015
[96]   Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study [J].
Storey, D. J. ;
Waters, R. A. ;
Hibberd, C. J. ;
Rush, R. W. ;
Cargill, A. T. ;
Wall, L. R. ;
Fallon, M. T. ;
Strong, V. A. ;
Walker, J. ;
Sharpe, M. .
ANNALS OF ONCOLOGY, 2007, 18 (11) :1861-1869
[97]  
Temple L, 1999, CAN MED ASSOC J, V18, P73
[98]   Quantifying fatigue in (long-term) colorectal cancer survivors: A study from the population-based Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry [J].
Thong, Melissa S. Y. ;
Mols, Floortje ;
Wang, Xin S. ;
Lemmens, Valery E. P. P. ;
Smilde, Tineke J. ;
van de Poll-Franse, Lonneke V. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) :1957-1966
[99]   Developing the World Health Organization Disability Assessment Schedule 2.0 [J].
Uestuen, T. Bedirhan ;
Chatterji, Somnath ;
Kostanjsek, Nenad ;
Rehm, Juergen ;
Kennedy, Cille ;
Epping-Jordan, Joanne ;
Saxena, Shekhar ;
von Korff, Michael ;
Pull, Charles .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (11) :815-823
[100]  
Ustun TB, 2009, MEASURING HLTH DISAB